Charlotte

Charlotte Insurer Bleeds $792 Million As $4.1 Billion Brighthouse Sale Nears

AI Assisted Icon
Published on May 11, 2026
Charlotte Insurer Bleeds $792 Million As $4.1 Billion Brighthouse Sale NearsSource: Google Street View

Brighthouse Financial just logged a bruising first quarter, posting a net loss of $792 million and giving Charlotte's insurance scene a bumpy start to 2026. The red ink lands as the company inches toward a roughly $4.1 billion cash sale that shareholders already signed off on earlier this year.

Quarterly results and what drove the loss

According to Brighthouse Financial, the insurer reported a GAAP net loss available to shareholders of $792 million for the quarter that ended March 31. Strip out notable items, and adjusted earnings came in at $251 million.

The core business kept humming: annuity sales totaled about $2.2 billion, with Shield Level Annuities leading the pack. The big swing on the GAAP line, the company said, largely reflects market-sensitive derivative losses and hedging activity tied to guarantees baked into its annuity products. In other words, when markets and interest rates jump around, the accounting on those protections can swing hard from quarter to quarter.

Deal status: shareholder vote clears hurdle

Shareholders already cast a crucial vote this year, approving a $70-per-share acquisition by an affiliate of Aquarian Capital, a deal that pegs Brighthouse's value at about $4.1 billion, as reported by the Charlotte Business Journal. Reuters and others have noted that Aquarian's backing includes Abu Dhabi-linked investors and that the buyer intends to keep Brighthouse running as a standalone business once the transaction closes.

The deal still is not a done deal yet. It remains subject to the usual checklist of closing conditions, including antitrust review and approvals from insurance regulators, before Brighthouse can officially change hands.

What the filings say

In its quarterly report to the U.S. Securities and Exchange Commission, Brighthouse said the GAAP results were driven mainly by net derivative losses and shifts in market risk benefits tied to hedging variable and indexed annuity guarantees. The company cautioned that quarterly earnings can look "lumpy" because those line items move with interest rates and overall market volatility, according to its filing with the SEC.

Brighthouse also reported an estimated combined risk-based capital ratio in the 430% to 450% range and said holding-company liquid assets were about $0.9 billion. The company highlighted those figures as cushions against market swings. Investors, already watching the pending sale closely, will also be tracking whether underwriting performance and hedging results settle down in coming quarters.

Local impact and operations

Headquartered in Charlotte's Ballantyne business park, Brighthouse sits squarely in the middle of the region's white-collar economy, so local leaders and employees are paying close attention. Company statements and comments from the buyers indicate Brighthouse is expected to keep operating in its current markets after the deal closes, and there have been no announcements of Charlotte-area layoffs tied specifically to the pending sale, according to the Charlotte Business Journal.

Even so, analysts note that private owners frequently reexamine cost structures once a deal is complete, which means changes could still arrive later, even if the transition looks quiet at first.

Regulatory hurdles and next steps

The transaction is still working its way through the regulatory maze. It remains subject to antitrust clearance and sign-offs from state insurance regulators, the parties said in public filings and in their original deal announcement on Business Wire. Both Brighthouse and Aquarian continue to expect the sale to close in 2026, though they have warned that timing could shift as regulators vet the transfer of policy liabilities.

Next up on the calendar: any public regulatory filings that shed light on the review and Brighthouse's second-quarter results, which will be scrutinized for signs that the buyer's deal economics and the insurer's capital position are holding up.

For Charlotte, the unfolding sale is another reminder that homegrown finance players can be buffeted by national markets and global private equity interest. Brighthouse executives have said the shareholder vote moved the company "one step closer" to closing the deal, and company materials point to annuity sales and capital metrics as reasons they believe the insurer can ride out near-term volatility, according to filings with the SEC.